Ethics approval and consent to participate
This trial was approved by the Ethical Review Committee of Peking University People’s Hospital (#2022PHB179-001) and registered in the Chinese Clinical Trial Registry (ChiCTR2200062017) on 19/07/2022. Written informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations.